Welcome to LookChem.com Sign In|Join Free

CAS

  • or

203519-01-1

1-[(4-BROMOPHENYL)SULFONYL]-4-PIPERIDINECARBOXYLIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

203519-01-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 203519-01-1 Structure

  • Basic information

    1. Product Name: 1-[(4-BROMOPHENYL)SULFONYL]-4-PIPERIDINECARBOXYLIC ACID
    2. Synonyms: AKOS BBS-00001493;1-(4-BROMO-BENZENESULFONYL)-PIPERIDINE-4-CARBOXYLIC ACID;1-[(4-BROMOPHENYL)SULFONYL]PIPERIDINE-4-CARBOXYLIC ACID;1-[(4-BROMOPHENYL)SULFONYL]-4-PIPERIDINECARBOXYLIC ACID
    3. CAS NO:203519-01-1
    4. Molecular Formula: C12H14BrNO4S
    5. Molecular Weight: 348.21
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 203519-01-1.mol

  • Chemical Properties

    1. Melting Point: 224-227°C
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-[(4-BROMOPHENYL)SULFONYL]-4-PIPERIDINECARBOXYLIC ACID(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-[(4-BROMOPHENYL)SULFONYL]-4-PIPERIDINECARBOXYLIC ACID(203519-01-1)
    11. EPA Substance Registry System: 1-[(4-BROMOPHENYL)SULFONYL]-4-PIPERIDINECARBOXYLIC ACID(203519-01-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 203519-01-1(Hazardous Substances Data)

203519-01-1 Usage

Chemical class

Sulfonamide compounds

Structure

A derivative of piperidinecarboxylic acid with a piperidine ring, a sulfonamide group, and a bromophenyl group

Pharmaceutical use

Commonly used in the pharmaceutical industry

Biological activities

Diverse biological activities

Potential applications

Antihypertensive and antithrombotic agent

Enzyme inhibition

Inhibitor of Angiotensin-converting enzyme (ACE), involved in blood pressure regulation

Neurodegenerative diseases

Investigated for potential use in treatment due to enzyme inhibition

Cancer treatment

Investigated for potential use in treatment due to enzyme inhibition

Molecular weight

Approximately 328.18 g/mol

Check Digit Verification of cas no

The CAS Registry Mumber 203519-01-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,5,1 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 203519-01:
(8*2)+(7*0)+(6*3)+(5*5)+(4*1)+(3*9)+(2*0)+(1*1)=91
91 % 10 = 1
So 203519-01-1 is a valid CAS Registry Number.

203519-01-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-bromophenyl)sulfonylpiperidine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-(4-bromobenzenesulfonyl)piperidine-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:203519-01-1 SDS

203519-01-1Downstream Products

203519-01-1Relevant articles and documents

Heterocyclic compounds useful as oxido-squalene cyclase inhibitors

-

Page column 13, 14, (2008/06/13)

This invention concerns heterocyclic derivatives of formula (I) which are useful in inhibiting oxido-squalene cyclase, processes for their preparation and pharmaceutical compositions containing them. The present invention is also concerned with heterocyclic derivatives capable of inhibiting cholesterol biosynthesis and hence in lowering cholesterol levels in blood plasma. The present invention also relates to methods of using such heterocyclic derivatives in diseases and medical conditions such as hypercholesterolemia and atherosclerosis.

Substituted pyrimidine derivatives and their pharmaceutical use

-

, (2008/06/13)

PCT No. PCT/GB97/02029 Sec. 371 Date Feb. 12, 1999 Sec. 102(e) Date Feb. 12, 1999 PCT Filed Jul. 25, 1997 PCT Pub. No. WO98/06705 PCT Pub. Date Feb. 19, 1998This invention concerns heterocyclic derivatives which are useful in inhibiting oxido-squalene cyclase, processes for their preparation and pharmaceutical compositions containing them. The present invention is also concerned with heterocyclic derivatives capable of inhibiting cholesterol biosynthesis and hence in lowering cholesterol levels in blood plasma. The present invention also relates to methods of using such heterocyclic derivatives in diseases and medical conditions such as hypercholesterolemia and atherosclerosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 203519-01-1